Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes - OneTrader
Part of the OneTrader ecosystem OurPaisa All Tools
OneTrade

Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes

Novo Nordisk has been swept up in uncertainty around U.S. tariffs and Washington’s push to get firms to lower drug prices and move manufacturing stateside.

Share this articleWhatsAppTelegramXLinkedInFacebook
Paisa LOL by OneTrader

Need a laugh after all that money talk?

Paisa LOL: India's funniest finance page, with memes, comics, jokes and long funny stories.

Take a laugh break →

Leave a Reply

Your email address will not be published. Required fields are marked *

Grow your business: advertise on onetrader.in